Michael R. Megna, Chief Accounting Officer: Kiniksa Pharmaceuticals International KNSA Sell · Filed 25/10/22

Trade details

Type: Insider sale
Amount: $520,267.85
Shares · price: 13,235 sh · $39.31 a share
Held after: 27,046 sh
Stock: Kiniksa Pharmaceuticals International KNSA
Person: Michael R. MegnaChief Accounting Officer
Trade date: 25/10/20
Filed: 25/10/22
Days to filing: 2 days

Sold 32.9% of holdings

Share of holding sold: 32.9%

Kiniksa Pharmaceuticals International trades, last 26 weeks

What else happened in Kiniksa Pharmaceuticals International around then

Filed or reported within 30 days of the trade day · 25/09/20~25/11/19

Michael R. Megna's recent trades

Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$369.4K
4,600 sh
$369.4K
Filed 09/03
Traded 09/03
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/13
Traded 04/09
Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/09
Traded 04/09
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$1.4M
37,255 sh
$1.4M
Filed 25/10/22
Traded 25/10/20
Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$2M
50,490 sh
$2M
Filed 25/10/20
Traded 25/10/20